Macadamian, together with Danish consortium partners Radiobotics and Bispebjerg Hospital, has been recognized by the Eurostars Network for driving innovation in the field of radiology.
Eurostars, a European funding program for innovative R&D projects, announced today that Macadamian has been recognized and ranked as the top project for the 2019 Eurostars Eureka innovation project funding for X-AID, an AI-driven radiology clinical decision support software tool. In addition to the award, Macadamian received a $495,000 grant from Eurostars and the National Research Council of Canada in April of this year. The subsidy is for a three-year period to develop and commercialize the solution.
Eurostars is a joint program between EUREKA and the European Commission, co-funded from the national budgets of 36 Eurostars Participating States and Partner Countries which include Canada through Horizon 2020. To date, Eurostars has funded more than 7,000 innovation projects worldwide with a total value of approximately $61 billion Canadian.
“We are thrilled to receive the grant and to be working on the development of a leading-edge diagnostic tool and we look forward to working with forward-thinking providers to pilot it”, said Frederic Boulanger, CEO Macadamian. Boulanger added “Our X-AID proposal was ranked an impressive 1st place submission beating out 283 eligible applicants. This is a very strong endorsement of our deep and wide experience in healthcare technology and analytics. This is something the whole team at Macadamian is extremely proud of.”
According to Timon LeDain, Director of Emerging Technologies, Macadamian “X-AID is focused on addressing the global challenge associated with the growing shortage of highly specialized radiologists in addition to the increasing demand to deliver faster and more accurate diagnoses of routine X-ray images of bones and joints. The solution is unique in that it uses fully automated machine learning (ML) algorithms and deep convolutional neural networks (CNNs) to deliver highly accurate diagnoses.”
X-AID is being developed on Macadamian HealthConnect™ a digital health Platform-as-a-Service that Macadamian’s healthcare experts use as the underlying architecture to accelerate the development of data-informed medical device and digital therapeutic software applications for our clients. Radiobotics, is providing the underlying AI and ML algorithms. Clinical evaluation of X-AID will be undertaken by the Bispebjerg Hospital and begin in October 2019.
We design and develop digital and connected experiences to improve healthcare. Macadamian is a full-service software design and development consulting firm that provides a complete range of product strategy, user experience design and research, and software engineering services. Ranging from big consumer brands to complex enterprise environments, our goal is to create solutions that are simple and meaningful, prioritizing the experience of the patient, the clinician, and the business needs of our clients.
Contact: Vani Edwardson, Vice President of Marketing
Email: [email protected] | Phone +1-819-772-0300 ext 287
Radiobotics is an AI algorithm start-up company, based in Denmark, that is challenging the status quo of musculoskeletal radiology, by automating routine tasks, alleviating the urgent need for specialized radiologists, whilst improving diagnostic quality.
Contact: Stine Mølgaard Sørensen, COO
Email: [email protected]
Bispebjerg Hospital is one of Denmark’s 4 emergency hospitals. The hospital serves over 455,000 citizens and has 530 beds, 80,000 emergency visits, and 400,000 outpatient visits per year.
Contact: Dr. Mikael Boeson, M.D., Ph.D., Head of Radiology
Email: [email protected]